So, for the first time, we systematically investigated the individual and synergistic effects of the variants of FASL, FAS and CASP8 on the response to platinum-based adjuvant chemotherapy for postoperative stage II-III GC patients on the basis of large amount of clinical data. Here, CASP8 is linked to gastric cancer.